2017 International Congress

June 4-8, 2017. Vancouver, BC.

View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Improving Racial and Ethnic Diversity in Parkinson`s Disease Clinical Trials

S. Ray, A. Madan, D. Burdick, A. Griffith, P. Agarwal (Kirkland, WA, USA)
Impulse control disorder and associated clinical factors in drug-naïve Parkinson’s disease.

D. Gupta, M. Marano, S. Fahn (New York, NY, USA)
Impulse Control Disorders in Early Onset and Familial PD

R. Rees, N. Williams, Y. Ben-Shlomo, D. Grosset, H. Morris (London, United Kingdom)
Impulse control disorders in Parkinson’s disease; description of a New Zealand cohort

A. Garvey, S. Buchanan, N. Cutfield (Dunedin, New Zealand)
Impulse Control Disorders in Parkinson’s Disease: Prevalence and Clinical Features in the Rush University Movement Disorders Clinic

M. Rossi, G. Stebbins, B. Barton (Chicago, IL, USA)
Impulsive-compulsive behaviors in patients with Parkinson´s disease in Kannur, India

N. Svensson, S. Ovallath, R. Constantinescu (Göteborg, Sweden)
In silico predictive analytics: accelerating identification of potential disease-modifying compounds for Parkinson’s disease

N. Visanji, A. Lacoste, S. Spangler, E. Argentinis, S. Ezell, C. Marras, L. Kalia (Toronto, ON, Canada)
In vivo evaluation of tau and amyloid pathology in Corticobasal Syndrome

F. Niccolini, H. Wilson, S. Hirschbichler, G. Pagano, R. Erro, T. Yousaf, A. Whittington, J. Holton, D. Martino, E. Rabiner, R. Gunn, K. Bhatia, M. Politis (London, United Kingdom)
In vivo mapping of nigro-striatal dopamine transporter (DAT) availability in early Parkinson´s disease patients using [18F]FE-PE2I and high-resolution positron emission tomography.

P. Fazio, P. Svenningsson, Z. Cselenyi, C. Halldin, L. Farde, A. Varrone (Stockholm, Sweden)
In-patient Parkinson courses and caregiver burden

K. Martikainen, S. Kinos, R. Marttila (Turku, Finland)

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z